Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study)

Maria Rubio-Valera,María T. Peñarrubia-María,Maria Iglesias-González,Martin Knapp,Paul McCrone,Marta Roig,Ramon Sabes-Figuera,Juan V. Luciano,Juan M. Mendive,Ana Gabriela Murrugara-Centurión,Jordi Alonso,Antoni Serrano-Blanco

Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study)

2019

Maria Rubio-Valera
María T. Peñarrubia-María
Maria Iglesias-González
Martin Knapp
Paul McCrone
Marta Roig
Ramon Sabes-Figuera
Juan V. Luciano
Juan M. Mendive
Ana Gabriela Murrugara-Centurión
Jordi Alonso
Antoni Serrano-Blanco

Background The purpose of this study was to evaluate the cost-effectiveness of antidepressants vs active monitoring (AM) for patients with mild–moderate major depressive disorder.

Keywords:

Health economics
Physical therapy
Randomized controlled trial
Active monitoring
Major depressive disorder
Medicine
Willingness to pay
Health care
Propensity score matching
Observational study
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations